Economic and Financial Impacts of Cancer
Economic and Financial Impacts of Cancer is a research topic within Economics and Econometrics. Science Explorer counts 21k research works in it since 1950. 20.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the economic burden and financial impact of cancer treatment, including the concept of financial toxicity, out-of-pocket costs, healthcare expenditure, cost communication, and drug pricing. It addresses the challenges related to the cost of care, financial hardship experienced by patients, and the implications for both patients and healthcare systems.
- Financial Toxicity
- Cost of Care
- Cancer Treatment Expenses
- Healthcare Expenditure
- Financial Hardship
- Medical Financial Burden
- Out-of-Pocket Costs
- Cost Communication
- Drug Pricing
- Productivity Costs
- Research works
- 21k fractional, since 1950
- In the world top 10%
- 4.2k per year above
- Top-10% rate
- 20.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +70% the tick is no change
Which countries lead Economic and Financial Impacts of Cancer research?
By volume, the United States and the United Kingdom publish the most (3.1k and 400 works in 2022–2025).
By volume, 2022–2025
- 1 United States 3.1k works
- 2 United Kingdom 400 works
- 3 China 309 works
- 4 Canada 232 works
- 5 Germany 182 works
- 6 India 170 works
- 7 France 155 works
- 8 Italy 128 works
- 9 Netherlands 128 works
- 10 Australia 126 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Economic and Financial Impacts of Cancer research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Economic and Financial Impacts of Cancer research, followed by The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center.
By volume, 2022–2025
- 1 University of North Carolina at Chapel HillUnited States 77 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 76 works
- 3 Memorial Sloan Kettering Cancer CenterUnited States 56 works
- 4 Harvard UniversityUnited States 44 works
- 5 University of MichiganUnited States 42 works
- 6 University of PennsylvaniaUnited States 37 works
- 7 Dana-Farber Cancer InstituteUnited States 35 works
- 8 University of California, San FranciscoUnited States 30 works
- 9 University of Alabama at BirminghamUnited States 30 works
- 10 Brigham and Women's HospitalUnited States 28 works
Where is Economic and Financial Impacts of Cancer research done?
The largest centres of Economic and Financial Impacts of Cancer research in 2022–2025 are New York (United States), Boston (United States), London (United Kingdom) and Philadelphia (United States).
Largest cities, 2022–2025
- 1 New York United States 214 works
- 2 Boston United States 165 works
- 3 London United Kingdom 133 works
- 4 Philadelphia United States 118 works
- 5 Houston United States 112 works
- 6 Chapel Hill United States 81 works
- 7 Toronto Canada 70 works
- 8 Atlanta United States 63 works
- 9 Los Angeles United States 63 works
- 10 Seattle United States 63 works
Where is the best place to study Economic and Financial Impacts of Cancer?
Among universities, judged by research, Harvard University, Queen's University and University of Alabama at Birmingham score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Harvard UniversityUnited States | 65.4 | 32.9% | 5.8× | 44 | +157.6% |
| 2 | Queen's UniversityCanada | 64.2 | 44.9% | 5.7× | 14 | +336.7% |
| 3 | University of Alabama at BirminghamUnited States | 58.7 | 17.8% | 10.3× | 30 | +146.4% |
| 4 | University of PennsylvaniaUnited States | 56.2 | 23.5% | 6.7× | 37 | +143.8% |
| 5 | Duke UniversityUnited States | 55.8 | 26.1% | 6.2× | 26 | +176.4% |
| 6 | University of North Carolina at Chapel HillUnited States | 55.2 | 11.0% | 7.4× | 77 | +158.1% |
| 7 | University of California, San FranciscoUnited States | 54.7 | 23.8% | 7.9× | 30 | +85.3% |
| 8 | Erasmus University RotterdamNetherlands | 49.9 | 47.9% | 5.5× | 10 | -16.4% |
| 9 | University of MichiganUnited States | 49.1 | 24.2% | 5.1× | 42 | +82.7% |
| 10 | Brown UniversityUnited States | 48.5 | 41.2% | 4.2× | 10 | +123.8% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Economic and Financial Impacts of Cancer research growing?
Output in 2018–2022 was 70% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Economic and Financial Impacts of Cancer.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.